相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
W-554; ADD-03055
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
25451-15-4
- 规格:
10 mM * 1 mL/5 mg/10 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥396.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥360.0 |
| 规格: | 10 mg | 产品价格: | ¥570.0 |
| 规格: | 50 mg | 产品价格: | ¥1824.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Felbamate
CAS No. : 25451-15-4
MCE 国际站:Felbamate
产品活性:Felbamate (W-554) 是非镇静性抗痉挛剂,活性与NMDA受体相关。
研究领域:Membrane Transporter/Ion Channel | Neuronal Signaling
作用靶点:iGluR
In Vitro: Felbamate (W-554) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy. Felbamate (W-554) has been proposed to a unique dual mechanism of action as a positive modulator of GABAA receptors and as a blocker of NMDA receptors, particularly isoforms containing the NR2B subunit. Although it is clear that felbamate does cause pharmacological inhibition of NMDA receptor of relevance of NMDA receptor blockade as a strategy for the treatment of human epilepsy has been questioned. Therefore, the importance of the effects of felbamate on NMDA receptors to its therapeutic action in epilepsy is uncertain.
相关产品:Covalent Screening Library Plus | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Membrane Transporter/Ion Channel Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | CNS-Penetrant Compound Library | Drug Repurposing Compound Library | Covalent Screening Library | Anti-COVID-19 Compound Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Alzheimer's Disease Compound Library | Neuroprotective Compound Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Rare Diseases Drug Library | Antidepressant Compound Library | Human Metabolite Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Mitochondrial Toxicity Compound Library | Ion Channel Compound Library | Corticosterone | D-AP5 | Dizocilpine maleate | NMDA | L-Glutamic acid | Evans Blue | CNQX | Kynurenic acid | Glycine | NBQX | Cycloleucine | L-Phenylalanine | Quinolinic acid | Memantine hydrochloride | Ifenprodil tartrate | D-Cycloserine | DNQX | Ro 25-6981 Maleate | Ibotenic acid | (-)-Huperzine A | Decanoic acid | Crocetin | Tat-NR2B9c TFA | Topiramate | Piracetam | 24-Hydroxycholesterol | Naspm trihydrochloride | Tacrine hydrochloride
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
















